Importantly, these data do not demonstrate that DRD3 plays a direct role in promoting chemo-resistance in GBM, only that DRD3 may serve as a useful therapeutic target in chemoresistant and/or recurrent GBM, which is extremely difficult to treat. Here, DRD3 is linked to glioblastoma.